Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 149, Issue 1, 1994, Pages 86-90

  Wilson, John W ^a   Djukanović, Ratko ^a   Howarth, Peter H ^a   Holgate, Stephen T ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; METHACHOLINE;

ADULT; ALLERGIC ASTHMA; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; INHALATIONAL DRUG ADMINISTRATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PROPHYLAXIS; T LYMPHOCYTE;

EID: 0028154064     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.149.1.8111605     Document Type: Article

References (41)

1. Subcommittee on clinical trial in asthma. Controlled trial of effect of cortisone acetate in status asthmaticus. Report of the Medical Research Council. Lancet 1956; 2:803-8.
2. Costello JF, Clark TJH. Response of patients receiving high-dose beclomethasone dipropionate. Thorax 1974; 29:571-3.
3. Toogood JH, LeFeoe NM, Haines DSM, Jennings B, Errington N, Baksh L, Chuang L. A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy Clin Immunol 1977; 59:298-308.
4. Bhagat RG, Grunstein MM. Effect of corticosteroids on bronchial responsiveness to methacholine in asthmatic children. Am Rev Respir Dis 1985; 131:902-6.
5. Jenkins CR, Woolcock AJ. Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: a comparative study. Thorax 1988; 43:378-84.
6. Kirby JG, Hargreave FE, Gleich GJ, O'Byrne PM. Bronchoalveolar lavage cell profiles of asthmatic and non-asthmatic subjects. Am Rev Respir Dis 1987; 136:379-83.
7. Wenzel SE, Fowler AA, Schwartz LB. Activation of pulmonary mast cells by bronchoalveolar allergen challenge: in vivo release of histamine and tryptase in atopic subjects with and without asthma. Am Rev Respir Dis 1988; 137:1002-8.
8. Kelly CA, Stenton SC, Ward C, Bird G, Hendrick DJ, Walters EM. Lymphocyte subsets in bronchoalveolar lavage fluid obtained from stable asthmatics and their correlations with bronchial responsiveness. Clin Exp Allergy 1989; 19:169-75.
9. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139:806-17.
10. Lundgren R. Scanning electron microscopic studies of bronchial mucosa before and during treatment with beclomethasone dipropionate inhalations. Scand J Respir Dis 1977; 101:(Suppl. 179-87).
11. Lundgren R, Soderberg M, Horstedt P, Stenling R. Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. Eur Respir J 1988; 1:883-9.
12. Wilson JW, Schrader JW, Pain MCF. Human bronchial mast cells. Proceedings of the XXXth Congress of the International Union of Physiological Sciences, Vancouver 1986; 123a (abstr).
13. Djukanović R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, Howarth PH, Holgate ST. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 1992; 145:669-74.
14. Adelroth E, Rosenhall L, Johansson S, Linden M, Venge P. Inflammatory cells and eosinophil activity in asthmatics investigated by bronchoalveolar lavage. Am Rev Respir Dis 1990; 142:91-9.
15. Dinarello CA, Mier JW. Lymphokines. N Engl J Med 1987; 317:940-5.
16. Crabtree GR. Contingent genetic regulatory events in T-lymphocyte activation. Science 1989; 243:355-61.
17. Djukanović R, Roche WR, Wilson JW, Beasley CRW, Twentyman OP, Holgate ST. State of the Art. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142:434-57.
18. Alam R, Kuna P, Rozniecki J, Kuzminska B. The magnitude of the spontaneous production of histamine-releasing factor (HRF) by lymphocytes in vitro correlates with the state of bronchial hyperreactivity in patients with asthma. J Allergy Clin Immunol 1987; 79:103-8.
19. Lebman DA, Coffman RL. Interleukin 4 causes isotype switching to IgE in T-cell-stimulated clonal B cell cultures. J Exp Med 1988; 168:853-62.
20. Hamid Q, Azzawi M, Ying S, Moqbel R, Wardlaw AJ, Corrigan CJ, Bradley B, Durham SR, Collins JV, Jeffery PK, Quint DJ, Kay AB. Expression of mRNA for interteukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991; 87:1541-6.
21. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB. Predominant Th2-like bronchoalveolar T-lymphocyte populations in atopic asthma. N Engl J Med 1992; 326:298-304.
22. Arya SK, Wong-Staal F, Gallo RC. Dexamethasone-mediated inhibition of human T-cell growth factor and gamma-interferon messenger RNA. J Immunol 1984; 133:273-6.
23. Reed JC, Abidi AH, Alpers JD, Hoover RG, Robb RJ, Nowell PC. Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression. J Immunol 1986; 137:150-4.
24. Pinkston P, Saltini C, Muller-Quernheim J, Crystal RG. Corticosteroid therapy suppresses spontaneous interleukin 2 release and spontaneous proliferation of lung T-lymphocytes of patients with active pulmonary sarcoidosis. J Immunol 1987; 139:755-60.
25. Gerblich AA, Campbell AE, Sohingler MR. Changes in T-lymphocyte sub-populations in asthmatics. N Engl J Med 1984; 310:1349-52.
26. Corrigan CJ, Hartnell A, Kay AB. T-lymphocyte activation in acute severe asthma. Lancet 1988; 1:1129-32.
27. Chai H, Farr RS, Froelick LA, Mathison DA, McLear JA, Rosenthal RR et al. Standardisation of bronchial inhalational challenge procedures. J Allergy Clin Immunol 1975; 56:323-7.
28. Djukanović R, Walls AF, Wilson JW, Walters C, Britten KM, Wilson S, Church MK, Howarth MK, Holgate ST. The effect of inhaled beclomethasone (BDP) on airway mast cells, histamine and tryptase in atopic asthma. Am Rev Respir Dis 1991; 143:627 (abstr).
29. Wilson JW, Djukanović R, Howarth PH, Holgate ST. Lymphocyte activation in bronchoalveolar lavage and peripheral blood in atopic asthma. Am Rev Respir Dis 1992; 145:958-60.
30. Azzawi M, Bradley B, Jeffery PK, Frew AJ, Wardlaw AJ, Knowles G, Assoufi B, Collins JV, Durham S, Kay AB. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable asthma. Am Rev Respir Dis 1990; 142:1407-13.
31. Gerblich AA, Salik H, Schluyer MR. Dynamic T-cell changes in peripheral blood and bronchoalveolar lavage after antigen bronchoprovocation in asthmatics. Am Rev Respir Dis 1991; 143:533-7.
32. Bradley BL, Azzawi M, Jacobson M, Assoufi B, Collins JV, Irani A-M A, Schwartz LB, Durham SR, Jeffery PK, Kay AB. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991; 88:661-74.
33. Metcalf D, Begley CG, Johnson GR, Nicola NA, Vadas MA, Lopez AF, Williamson DJ, Wong GG, Clark SC, Wang EA. Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1986; 67:37-45.
34. Campbell HD, Tucker WQJ, Hort Y, Martinson ME, Mayo G, Clutterbuck EJ, Sanderson CJ, Young IG. Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin 5). Proc Natl Acad Sci USA 1987; 84:6629-33.
35. Irani A-M, Craig SS, De Blois G, Elson CO, Schlechter NM, Schwartz LB. Deficiency of the tryptase positive, chymase negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. J Immunol 1987; 138:4381-6.
36. Hamaguchi Y, Kanakura Y, Fujita J, Takeda SI, Nakano T, Seiichiro T, Honjo T, Kitamura Y. Interleukin 4 as an essential factor for in vitro clonal growth of murine connective tissue-type mast cells. J Exp Med 1987; 165:268-73.
37. Culpepper JA, Lee F. Regulation of IL-3 expression by glucocorticoids in cloned murine T lymphocytes. J Immunol 1985; 135:3191-7.
38. Pauwels R. Mode of action of corticosteroids in asthma and rhinitis. Clin Allergy 1986; 16:281-8.
39. Svensjo E, Roempke K. Time-dependent inhibition of bradykinin- and histamine-induced increase in microvascular permeability by local glucocorticosteroid treatment. In: Hogg JC, Ellul-Micallef R, Brattsand R, eds. Glucocorticosteroids, inflammation and bronchial hyperreactivity. Amsterdam: Excerpta Medica, 1984; 136-44.
40. Hui KK, Conolly ME, Tashkin DP. Reversal of human lymphocyte beta-adrenoceptor desensitization by glucocorticoids. Clin Pharmacol Ther 1982; 32:566-71.
41. Prasad CM, Adamski SW, Svensjo E, Grega CJ. Pharmacological modification of the edema produced by combined infusions of prostaglandin E and bradykinin in canine forelimbs. J Pharmacol Exp Ther 1982; 220:293-8.